This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Xuejun Chen
Introduction: Xuejun Chen is a notable inventor based in Clarksburg, MD, who has made significant contributions to the field of immunology. His work primarily focuses on developing innovative solutions to combat HIV-1 infections. With a total of two patents to his name, Chen's research is paving the way for advancements in vaccine development.
Latest Patents: Xuejun Chen's latest patents include "Glycan-masked engineered outer domains of HIV-1 gp120 and their use." This patent discloses embodiments of immunogens based on the outer domain of HIV-1 gp120, along with methods of their use and production. The patent also provides nucleic acid molecules encoding these immunogens. In several embodiments, these immunogens can be utilized to prime an immune response to gp120 in a subject, potentially treating or preventing an HIV-1 infection.
Career Highlights: Chen is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to engage in groundbreaking research that has the potential to save lives and improve public health.
Collaborations: Some of Xuejun Chen's notable coworkers include Jeffrey C Boyington and Hongying Duan Holdsworth. Their collaborative efforts contribute to the advancement of research in immunology and vaccine development.
Conclusion: Xuejun Chen's innovative work and patents reflect his commitment to addressing critical health challenges, particularly in the fight against HIV-1. His contributions are vital to the ongoing efforts in immunology and vaccine research.